Literature DB >> 15152067

Medicare coverage for technological innovations--time for new criteria?

Muriel R Gillick1.   

Abstract

Keywords:  Health Care and Public Health

Mesh：

Year:  2004        PMID： 15152067     DOI： 10.1056/NEJMsb032612

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension.

Authors:  Steven M Kymes; Michael R Plotzke; Michael A Kass; Michael V Boland; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2010-05

Review 2.  The pre-sports cardiovascular evaluation: should it depend on the level of competition, the sport, or the state?

Authors:  Yaniv Bar-Cohen; Michael J Silka
Journal:  Pediatr Cardiol       Date:  2012-02-11       Impact factor: 1.655

3.  Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Rebecca I Hartman; Mukesh G Harisinghani; Adam S Feldman; Peter R Mueller; G Scott Gazelle
Journal:  Radiology       Date:  2010-09       Impact factor: 11.105

Review 4.  Economic evaluation in the US: what is the missing link?

Authors:  Peter J Neumann; Sean D Sullivan
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

5.  Ironic technology: Old age and the implantable cardioverter defibrillator in US health care.

Authors:  Sharon R Kaufman; Paul S Mueller; Abigale L Ottenberg; Barbara A Koenig
Journal:  Soc Sci Med       Date:  2010-11-11       Impact factor: 4.634

Review 6.  [Treating ICD patients at the end of their lives: attitudes, knowledge, and behavior of doctors and patients. A critical literature analysis].

Authors:  K-H Ladwig; N F Ischinger; J Ronel; C Kolb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-09

7.  Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Peter R Mueller; Chin Hur; G Scott Gazelle
Journal:  Radiology       Date:  2008-05-05       Impact factor: 11.105

Review 8.  Primary prevention of sudden cardiac death.

Authors:  Leonard I Ganz
Journal:  Curr Cardiol Rep       Date:  2004-09       Impact factor: 2.931

9.  Cost-effectiveness analysis of therapies for chronic kidney disease patients on dialysis: a case for excluding dialysis costs.

Authors:  Daniel T Grima; Lisa M Bernard; Elizabeth S Dunn; Philip A McFarlane; David C Mendelssohn
Journal:  Pharmacoeconomics       Date:  2012-11-01       Impact factor: 4.981

10.  Economic evaluation of plerixafor for stem cell mobilization.

Authors:  Steven M Kymes; Iskra Pusic; Dennis L Lambert; Martin Gregory; Kenneth R Carson; John F DiPersio
Journal:  Am J Manag Care       Date:  2012-01       Impact factor: 2.229
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.